Читать книгу Autoimmune Liver Disease - Группа авторов - Страница 3

1 Chapter 2Table 2.1 Comparison of classic autoimmunity with AIH, PBC or PSC.Table 2.2 Comparison of selected features of innate and adaptive immunity.Table 2.3 Current and future therapeutic approaches to control autoimmune dis...

2 Chapter 3Table 3.1 Heritability of selected autoimmune or immune‐mediated disorders, m...Table 3.2 Genome‐wide association studies (GWAS) or related study designs o...Table 3.3 Genome‐wide association studies (GWAS) or related study designs ...Table 3.4 Genome‐wide association studies (GWAS) or related study designs o...Table 3.5 HLA locus associations in primary sclerosing cholangitis (PSC), prim...Table 3.6 Risk loci and candidate genes for primary biliary cholangitis.Table 3.7 Risk loci and candidate genes for primary sclerosing cholangitis.

3 Chapter 4Table 4.1 Clinical significance of anti‐nuclear antibody in autoimmune liver ...Table 4.2 Main features of the liver‐relevant autoimmune serologic specificit...

4 Chapter 5Table 5.1 Bacteria linked with primary biliary cholangitis (PBC) and the deve...Table 5.2 Comparison of environmental factors linked with PBC.

5 Chapter 6Table 6.1 Clinical Presentation of autoimmune hepatitis in adults and childre...Table 6.2 Revised Original Scoring System of the International Autoimmune Hep...

6 Chapter 7Table 7.1 Symptoms and signs in PBC.Table 7.2 Biochemical response criteria for risk stratification in UDCA‐treat...

7 Chapter 8Table 8.1 Differences between adult primary sclerosing cholangitis (PSC) and ...

8 Chapter 9Table 9.1 Disease nomenclature that forms part of the IgG4‐RD spectrum and ta...Table 9.2 HISORt^a criteria for AIP.Table 9.3 The Comprehensive Diagnostic Criteria for all manifestations of IgG...Table 9.4 The Boston consensus criteria for the histologic diagnosis (generic...

9 Chapter 10Table 10.1 Possible causes of seronegative acute liver failure.Table 10.2 King's College criteria for liver transplantation in ALF.Table 10.3 Clichy criteria for selection of ALF patients for liver transplant...Table 10.4 Refined UK listing criteria for super‐urgent liver transplantation...Table 10.5 Potential causes of cryptogenic cirrhosis.Table 10.6 Features on liver biology/histology that may suggest an underlying...

10 Chapter 11Table 11.1 Pregnancy outcomes in women with autoimmune hepatitis.Table 11.2 Impact of pregnancy on liver disease.Table 11.3 Cases ofde novo autoimmune hepatitis during pregnancy or postpartu...Table 11.4 Drug safety in pregnancy.Table 11.5 Practical management of autoimmune hepatitis (AIH) in pregnancy.

11 Chapter 12Table 12.1 Prevalence of osteoporosis and fractures according to the severity...Table 12.2 Risk factors for bone loss.Table 12.3 Effect of different oral bisphosphonates on lumbar spine and femor...

12 Chapter 13Table 13.1 Diagnostic criteria for recurrence autoimmune liver diseases after...Table 13.2 Frequency and risk factors for recurrence of autoimmune liver dise...

13 Chapter 14Table 14.1 Patient and graft survival at 5 and 10 years after LT in PBC, PSC ...Table 14.2 Incidence and time to recurrence of PBC after LT.Table 14.3 Incidence and risk factors of recurrence of PSC after LT.Table 14.4 Incidence and risk factors of recurrence of AIH after LT.

14 Chapter 15Table 15.1 Features of autoimmune liver diseases.Table 15.2 Proposed criteria for diagnosis of overlap syndrome.

15 Chapter 16Table 16.1 The most frequent EHAIDs in patients with AILDs.Table 16.2 Differences between SLE‐associated hepatitis and autoimmune hepati...Table 16.3 Initial serologic investigation for suspicion of EHAIDs in AILDs.

16 Chapter 17Table 17.1 Stepwise approach to the management of pruritus in PSC or PBC.Table 17.2 Stepwise approach to the management of fatigue in PBC.